Diana I Salnikova (Diana Salnikova)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Cell Cycle Arrest

Breast Cancer Cells

Top Venues

Investigational new drugs

Pharmaceuticals (Basel, Switzerland)

Diseases (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yulia A Volkova, Alexander M Scherbakov, Yaraslau U Dzichenka, Alexander Y Komkov, Fedor B Bogdanov, Diana I Salnikova, Andrey Dmitrenok, Antos Sachanka, Danila Sorokin, Igor Zavarzin
Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells. RSC medicinal chemistry 15 (7) (2024)
Diana I Salnikova, Nikita G Nikiforov, Anton Y Postnov, Alexander N Orekhov
Target Role of Monocytes as Key Cells of Innate Immunity in Rheumatoid Arthritis. Diseases (Basel, Switzerland) 12 (5) (2024)
Yulia A Volkova, Alexander M Scherbakov, Yaraslau U Dzichenka, Alexander Y Komkov, Fedor B Bogdanov, Diana I Salnikova, Andrey Dmitrenok, Antos Sachanka, Danila Sorokin, Igor Zavarzin
Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells. RSC medicinal chemistry 15 (7) (2024)
Diana I Salnikova, Nikita G Nikiforov, Anton Y Postnov, Alexander N Orekhov
Target Role of Monocytes as Key Cells of Innate Immunity in Rheumatoid Arthritis. Diseases (Basel, Switzerland) 12 (5) (2024)
Stepan K Krymov, Diana I Salnikova, Lyubov G Dezhenkova, Fedor B Bogdanov, Alexander A Korlyukov, Alexander M Scherbakov, Andrey E Shchekotikhin
Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs 41 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Stepan K Krymov, Diana I Salnikova, Lyubov G Dezhenkova, Fedor B Bogdanov, Alexander A Korlyukov, Alexander M Scherbakov, Andrey E Shchekotikhin
Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Stepan K Krymov, Diana I Salnikova, Lyubov G Dezhenkova, Fedor B Bogdanov, Alexander A Korlyukov, Alexander M Scherbakov, Andrey E Shchekotikhin
Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Yuri Yu Shchegolev, Danila V Sorokin, Alexander M Scherbakov, Olga E Andreeva, Diana I Salnikova, Ekaterina I Mikhaevich, Margarita V Gudkova, Mikhail A Krasil'nikov
Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells. BioImpacts : BI 13 (4) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs 41 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs 41 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)
Maria V Zapevalova, Ekaterina S Shchegravina, Irina P Fonareva, Diana I Salnikova, Danila V Sorokin, Alexander M Scherbakov, Alexander A Maleev, Stanislav K Ignatov, Ivan D Grishin, Alexander N Kuimov, Mariya Vladimirovna Konovalova, Elena V Svirshchevskaya, Alexey Yu Fedorov
Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway. International journal of molecular sciences 23 (18) (2022)
Stepan K Krymov, Alexander M Scherbakov, Lyubov G Dezhenkova, Diana I Salnikova, Svetlana E Solov'eva, Danila V Sorokin, Daniela Vullo, Viviana De Luca, Clemente Capasso, Claudiu T Supuran, Andrey E Shchekotikhin
Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Stepan K Krymov, Alexander M Scherbakov, Lyubov G Dezhenkova, Diana I Salnikova, Svetlana E Solov'eva, Danila V Sorokin, Daniela Vullo, Viviana De Luca, Clemente Capasso, Claudiu T Supuran, Andrey E Shchekotikhin
Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Stepan K Krymov, Alexander M Scherbakov, Lyubov G Dezhenkova, Diana I Salnikova, Svetlana E Solov'eva, Danila V Sorokin, Daniela Vullo, Viviana De Luca, Clemente Capasso, Claudiu T Supuran, Andrey E Shchekotikhin
Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)
Stepan K Krymov, Alexander M Scherbakov, Lyubov G Dezhenkova, Diana I Salnikova, Svetlana E Solov'eva, Danila V Sorokin, Daniela Vullo, Viviana De Luca, Clemente Capasso, Claudiu T Supuran, Andrey E Shchekotikhin
Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)
Diana I Salnikova, Varvara Orekhova, Andrey Grechko, Antonina Starodubova, Evgeny E Bezsonov, Tatyana Popkova, Alexander N Orekhov
Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis. International journal of molecular sciences 22 (16) (2021)